Literature DB >> 24685218

[Prokineticins: new regulatory peptides in human reproduction].

Sophie Brouillet1, Pascale Hoffmann1, Nadia Alfaidy2, Jean-Jacques Feige2.   

Abstract

During the last decade, there has been growing evidence for the involvement of prokineticins and their receptors (PROK/PROKR) in human reproduction, with multiple roles in the female and male reproductive systems. The PROK/PROKR signalling complex has been reported as a new actor in ovary, uterus, placenta, and testis physiology, with marked dysfunction in various pathological conditions such as polycystic ovary syndrome, recurrent pregnancy loss, preeclampsia, and ectopic pregnancy. Altogether, the results strongly suggest the involvement of prokineticins in spermatogenesis, oocyte competence, embryo implantation, pregnancy, and delivery, and argue for the clinical relevance of these cytokines and their receptors as diagnostic markers for several reproductive diseases.
© 2014 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24685218     DOI: 10.1051/medsci/20143003015

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  2 in total

1.  Effect of high ovarian response on the expression of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in peri-implantation endometrium in IVF women.

Authors:  Li-Zhen Xu; Min-Zhi Gao; Li-Hua Yao; A-Juan Liang; Xiao-Ming Zhao; Zhao-Gui Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  The Emerging Role of the Prokineticins and Homeobox Genes in the Vascularization of the Placenta: Physiological and Pathological Aspects.

Authors:  Nadia Alfaidy; Sophie Brouillet; Gayathri Rajaraman; Bill Kalionis; Pascale Hoffmann; Tiphaine Barjat; Mohamed Benharouga; Padma Murthi
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.